|
1. Cao L, Chen DL, Lee C, Chan CM, Chan KM, Vanittanakom N, Tsang DNC, Yuen KY. Detection of specific antibodies to an antigenic mannoprotein for diagnosis of Penicillium marneffei penicillosis. Journal of Clinical Microbiology 1998; 36(10): 3028-3031. 2. Cooper CR Jr, McGinnis MR. Pathology of Penicillium marneffei. Archives of Pathology Laboratory Medicine 1997; 121(8): 798-804. 3. Dixon DM, McNeil MD, Cohen ML, Gellin BG, La Montagne JR. Fungal infections: a growing threat. Public Health Reports 1996; 111(3): 226-235. 4. Duong TA. Infection due to Penicillium marneffei, an emerging pathogen: review of 155 reported cases. Clinical Infect Dis 1997 May;24(5):1026 Clinical Infectious Diseases 1996; 23(l):125-130. 5. Espinel-Ingroff A, Barchiesi F, Hazen C, Martinez-Suarez JV, Scalise G. Standardization of antifungal susceptibility testing and clinical relevance. Medical Mycology 1998; 36(Suppl 1): 68-78. 6. Fothergill AW. Identification of dematiaceous fungi and their role in human disease. Clinical Infectious Diseases 1996; 22(Suppl 2): S179-184. 7. Gold WL, Vellend H, Salit IE, Campbell I, Summerbell R, Rinaldi M, Simor AE. Successful treatment of systemic and local infections due to Exophiala species. Clinical Infectious Diseases 1994; 19(2): 339-341. 8. Hamilton AJ. Serodiagnosis of histoplasmosis, paracoccidioidomycosis and penicilliosis mameffei; current status and future trends. Medical Mycology 1998; 36(6): 351-364. 9. Hung CC, Hsueh PR, Chen MY, Hsiao CH, Chang SC, Luh KT. Invasive infection caused by Penicillium marneffei: an emerging pathogen in Taiwan. Clinical Infectious Diseases 1998; 26(l): 202-203. 10. Hung CC, Hsueh PR, Hsieh SM, Liu CJ, Chen MY, Luh KT. Bacteremia and fungemia in patients with advanced human immunodeficiency virus(HIV) infection in Taiwan. Journal of the Formosan Medical Association 1998; 97(10): 690-697. 11. Kawasaki M, Ishizaki H, Nishimura K, Miyaji M. Mitochondrial DNA analysis of Exophialia jeanselmei and Exophiala dermatitidis. Mycopathologia 1990; 110: 107-112. 12. Leslie Collier, Albert Balows, Max Sussman, Libero Ajello, Riderick J Hay. 1998. Topley & Wilson''s Microbiology and Microbial Infections, 9th edition, Vol.4: Medical Mycology. Oxford University Press, Inc., New York. 13. Manian FA, Brischetto MJ. Pulmonary infection due to Exophia1a jeanselmei: successful treatment with ketoconazole. Clinical Infectious Diseases 1993; 16: 455-456. 14. Masuda M, Naka W, Tajima S, Harada T, Nishikawa T, Kaufman L, Standard P. Deoxyribonucleic acid hybridization studies of Exophiala dermatitidis and Exophiala jeanselmei. Micrbiol. Immunol. 1989; 33(8): 631-639. 15. Merz WG, Khazan U, Jabra-rizk MA, Wu LC Osterhout GJ. Strain delineation and epidemiology of Candida(Clavispora) lusitaniae. Journal of Clinical Microbiology 1992; 30(2): 449-454. 16. Perfect JR, Schell WA. The new fungal opportunists are coming. Clinical Infectious Diseases 1996; 22(Suppl 2): S112-118. 17. Pfaller MA. Epidemiological typing methods for mycoses. Clinical Infectious Diseases 1992; 14(Suppl 1): S4-10. 18. Rath PM, Muller KD, Dermoumi H, Ansorg R. A comparison of methods of phenotypic and phenotypic fingerprinting of Exophiala dermatitidis isolated from sputum samples of patients with cystic fibrosis. Journal of Medical Microbiology 1997; 46(9): 757-762. 19. Rossmann SN, Cernoch PL, Davis JR. Dematiaceous fungi are an increasing cause of human disease. Clinical Infectious Diseases 1996; 22(l):73-80. 20. Scherer S, Stevens DA. Application of DNA Typing methods to epidemiology and taxonomy of Candida species. Journal of Clinical Microbiology 1987; 25(4): 675-679. 21. Sirisanthana T, Supparatpinyo K, Perriens J, Nelson KE. Amphotericin B and itraconazole for treatment of disseminated Penicllium marneffei infection in human immunodeficiency virus-infected patients. Clinical Infectious Diseases 1998; 26(5):1107-1110. 22. Sudduth EJ, Crumbley AJ 3d, Farrar WE. Phaeohyphomycosis due to Exophia1a species: clinical spectrum of disease in humans. Clinical Infectious Diseases 1992; 15(4): 639-644. 23. Supparapinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast asia. Lancet 1994; 344: 110-113. 24. Taylor JW, Geiser DM, Burt A, Koufopanou V. The evolutionary biology and population genetics underlying fungal strain typing. Clinical Microbiology Reviews 1999; 12(1): 126-146. 25. Van Burik JAH, Schreckhise RW, White TC, Bowden RA, Mterson D. Comparison of six extraction techniques for isolation of DNA from filamentous fungi. Medical Mycology 1998; 36: 299-303. 26. Vanittanakom N, Cooper CR, Chariyalertsak S, Youngchim S, Nelson KE, Sirisanthana T. Restriction endonuclease analysis of Penicillium marneffei. Journal of Clinical Microbiology 1996; 34(7): 1834-1836. 27. Vanittanakom N, Merz WG, Sittisombut N, Khamwan C, Nelson KE, Sirisanthana T. Specific identification of Penicllium marneffei by a polymerase chain reaction/hybridization technique. Medical Mycology 1998; 36(3):169-175. 28. Welch DF. Application of cellular fatty acid analysis. Clinical Microbiology Reviews 1991; 4(4): 422-438. 29. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clinical Microbiology Reviews 1998; 11(2): 382-402. 30. Zelles L. Phospholipid fatty acid profiles in selected members of soil microbial communities. Chemosphere 1997; 35: 276-294.
|